Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 9 (September)

1. Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.
   J Clin Oncol, 23(25): 5929-37. [Abstract] [Full-text]
2. Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
   J Clin Oncol, 23(25): 5918-28. [Abstract] [Full-text]
3. Is the risk of lung cancer reduced among eczema patients?
   Am J Epidemiol, 162(6): 542-7. [Abstract] [Full-text]
4. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
   J Clin Oncol, 23(25): 5910-7. [Abstract] [Full-text]
5. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
   J Clin Oncol, 23(25): 5883-91. [Abstract] [Full-text]
6. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
   J Clin Oncol, 23(25): 5892-9. [Abstract] [Full-text]
7. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
   J Clin Oncol, 23(25): 5900-9. [Abstract] [Full-text]
8. Primary epithelial lung malignancies in the pediatric population.
   Pediatr Blood Cancer, 45(5): 683-6. [Abstract] [Full-text]
9. Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
   Oncogene, 24(38): 5821-6. [Abstract] [Full-text]
10. Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection.
    Oncogene, 24(38): 5914-22. [Abstract] [Full-text]
11. Serum PDGF-AB in pleural mesothelioma.
    Tumour Biol, 26(5): 221-6. [Abstract] [Full-text]
12. Optical coherence tomography characteristics of choroidal metastasis.
    Ophthalmology, 112(9): 1612-9. [Abstract] [Full-text]
13. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
    J Natl Cancer Inst, 97(17): 1272-86. [Abstract] [Full-text]
14. Drug interaction between gefitinib and warfarin.
    Jpn J Clin Oncol, 35(8): 478-82. [Abstract] [Full-text]
15. Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.
    Am J Physiol Lung Cell Mol Physiol, 289(4): L591-8. [Abstract] [Full-text]
16. Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro.
    J Membr Biol, 204(2): 67-75. [Abstract] [Full-text]
17. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Surgery, 138(2): 360-7. [Abstract] [Full-text]
18. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
    Cancer Genet Cytogenet, 162(1): 10-20. [Abstract] [Full-text]
19. Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping.
    Cancer Genet Cytogenet, 162(1): 1-9. [Abstract] [Full-text]
20. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue.
    J Histochem Cytochem, 53(9): 1159-66. [Abstract] [Full-text]
21. iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: mechanism of cell survival in solid tumor core.
    Am J Physiol Cell Physiol, 289(4): C918-33. [Abstract] [Full-text]
22. No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese females.
    Neurosci Lett, 389(3): 121-3. [Abstract] [Full-text]
23. Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Leuk Res, 29(11): 1361-4. [Abstract] [Full-text]
24. Smoking habit and genetic factors associated with lung cancer in a population highly exposed to arsenic.
    Toxicol Lett, 159(1): 32-7. [Abstract] [Full-text]
25. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study.
    Int J Cancer, 117(4): 662-6. [Abstract] [Full-text]
26. Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer.
    Int J Cancer, 117(3): 398-408. [Abstract] [Full-text]
27. Statistical modeling and projections of lung cancer mortality in 4 industrialized countries.
    Int J Cancer, 117(3): 476-85. [Abstract] [Full-text]
28. Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker.
    Int J Cancer, 117(3): 460-8. [Abstract] [Full-text]
29. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer.
    Oncology, 69(2): 167-74. [Abstract] [Full-text]
30. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
    Radiology, 237(1): 342-7. [Abstract] [Full-text]
31. Effect of CT image compression on computer-assisted lung nodule volume measurement.
    Radiology, 237(1): 83-8. [Abstract] [Full-text]
32. Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy--initial findings.
    Radiology, 237(1): 295-300. [Abstract] [Full-text]
33. Exclusion of lung metastases in placental site trophoblastic tumor using [18F]fluorodeoxyglucose positron emission tomography: a case report.
    Gynecol Oncol, 99(1): 239-42. [Abstract] [Full-text]
34. An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapy.
    Biotechnol Bioeng, 92(2): 238-49. [Abstract] [Full-text]
35. Effect of smoking reduction on lung cancer risk.
    JAMA, 294(12): 1505-10. [Abstract] [Full-text]
36. Dietary phytoestrogens and lung cancer risk.
    JAMA, 294(12): 1493-504. [Abstract] [Full-text]
37. Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
    Br J Cancer, 93(7): 763-9. [Abstract] [Full-text]
38. UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial.
    Br J Cancer, 93(7): 770-3. [Abstract] [Full-text]
39. Systematic review of the relationship between family history and lung cancer risk.
    Br J Cancer, 93(7): 825-33. [Abstract] [Full-text]
40. Indoor radon and lung cancer: a case-control study.
    Isotopes Environ Health Stud, 41(2): 169-76. [Abstract] [Full-text]
41. Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trials.
    J Clin Oncol, 23(28): 6941-8. [Abstract] [Full-text]
42. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    J Clin Oncol, 23(28): 6873-80. [Abstract] [Full-text]
43. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
    J Clin Oncol, 23(28): 6865-72. [Abstract] [Full-text]
44. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
    J Clin Oncol, 23(28): 6854-64. [Abstract] [Full-text]
45. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
    J Clin Oncol, 23(28): 6846-53. [Abstract] [Full-text]
46. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.
    J Clin Oncol, 23(28): 6829-37. [Abstract] [Full-text]
47. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
    J Clin Oncol, 23(28): 6838-45. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.